Felix James Baker
Independent DirectorDr. Felix James Baker, Ph.D. M.D. is Independent Non-Executive Director of BeOne Medicines AG from June 11, 2026. He is Independent Director of Bicycle Therapeutics plc from April 18, 2024 and its Independent Chairman since June 17, 2025. Dr. Baker had been Lead Independent Director at Kymera Therapeutics, Inc. since March 28, 2024 until June 2026 and Chairman since June 2026. He serves as a Director of SlipChip Corp. He serves as a Lead Independent Director at Kiniksa Pharmaceuticals International, plc (formerly known as Kiniksa Pharmaceuticals, Ltd.) since October 2015. He served as Chairman of the Board at Talis Biomedical Corporation until March 10, 2023 and had been its Director since June 2013 until March 10, 2023. He served as Director at IGM Biosciences, Inc since January 26, 2021 and was its Independent Director until August 14, 2025. He serves as the Co-Managing Member and Limited Partner at Baker Bros. Advisors LP. Dr. Baker co-founded a biotechnology focused investing Partnership, which the Bakers have managed since 1994. Dr. Baker has managed healthcare investments for the Tisch family since 1994 as well as other investment Partnerships focused on the life sciences industry. He serves as Managing Director at Baker Brothers Investments. Dr. Baker founded Baker Brothers Advisors, together with his brother Julian Baker, in 2000. Dr. Baker served as the Chairman of Synageva BioPharma Corp. until June 22, 2015. He served as an Independent Director at Genomic Health, Inc. from July 26, 2012 to November 8, 2019. Dr. Baker served as Independent Director of Alexion Pharmaceuticals, Inc. since June 23, 2015 until February 16, 2021. Dr. Baker has been an Independent Director of Ardea Biosciences, Inc. since February 2010. He serves as Director of Kodiak Sciences Inc since September 2015. Dr. Baker has been a Director of Seagen Inc. since July 2003 and serves as its Independent Chair of the Board since May 15, 2022 also served as its Lead Independent Director since February 2005 until 2022. He serves on the Board of Trustees of The Stanford University. He is Co-Owner of FBB3 LLC and FBB Associates. He is Co-Managing Member at Baker/Tisch Investments, L.P. He served as Board Observer of Neoleukin Therapeutics, Inc. Dr. Baker served as a Director of Synageva BioPharma Corp. from October 2000 to June 22, 2015. He served as an Independent Director of Neurogen Corporation since May 1999. Dr. Baker served as a Director of Trimeris Inc. since April 2004, ConjuChem, LLC (alternate name, ConjuChem Biotechnologies, Inc.) from 2001 to February 2010, Anormed Inc. since April 27, 2004 and Presidio Pharmaceuticals, Inc. since August 29, 2007 and Cellegy Pharmaceuticals Inc. He served as Board Observer of Aquinox Pharmaceuticals Inc. He serves on the Board of N-Power Medicine. Dr. Baker holds a B.S. in Biology with Honors and a Ph.D. in Immunology from Stanford University and also completed medical school.
Positions
- Company NameKodiak Sciences Inc.Stock CodeKODPositionIndependent DirectorColleagues
- VPVictor PerlrothCo-Founder, Chairman, CEO & President
- JAJohn A. BorgesonExecutive VP, CFO & Secretary
- WTWayne ToChief Technology Officer
- DSDolly S. ChangChief Scientific Officer
- HLHong LiangSenior Vice President of Development
- RARobert A. ProfusekLead Independent Director
- CACharles A. BancroftIndependent Director
- BIBassil I. DahiyatIndependent Director
- Company NameBicycle Therapeutics plcStock CodeBCYCPositionIndependent ChairmanColleagues
- KLKevin LeeCEO & Executive Director
- FJFelix James BakerIndependent Chairman
- MSMichael SkynnerChief Scientific Officer
- AMAlistair MilnesChief Corporate Development Officer
- CHChristian HeinisScientific Founder
- TTTravis ThompsonChief Financial Officer
- JGJose-Carlos Gutierrez-RamosIndependent Non-Executive Director and Member of Research & Innovation Advisory Board
- SSStephen SandsIndependent Director
- HHHerve HoppenotIndependent Director
- Company NameKymera Therapeutics, Inc.Stock CodeKYMRPositionIndependent ChairmanColleagues
- NMNello MainolfiCo-Founder, President, CEO & Director
- FJFelix James BakerIndependent Chairman
- BNBruce N. JacobsChief Financial Officer
- BRBrian R. AdamsChief Legal Officer & Corporate Secretary
- JAJared A. GollobAdvisor
- NGNoah GoodmanChief Business Officer
- JWJeffrey W. AlbersIndependent Director
- PEPamela EspositoIndependent Director
- EHElena H. RidloffIndependent Director
